Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina

Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials. Thus, improving the efficiency of viral gene delivery has become increasingly important to increase the success of clinical trials. In this study, structural domains of diffe...

Full description

Bibliographic Details
Main Authors: Charbel Issa, P, Silva, D, Lipinski, D, Singh, MS, Mouravlev, A, You, Q, Barnard, A, Hankins, M, During, M, Maclaren, R
Format: Journal article
Language:English
Published: Public Library of Science 2013
_version_ 1797067404689276928
author Charbel Issa, P
Silva, D
Lipinski, D
Singh, MS
Mouravlev, A
You, Q
Barnard, A
Hankins, M
During, M
Maclaren, R
author_facet Charbel Issa, P
Silva, D
Lipinski, D
Singh, MS
Mouravlev, A
You, Q
Barnard, A
Hankins, M
During, M
Maclaren, R
author_sort Charbel Issa, P
collection OXFORD
description Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials. Thus, improving the efficiency of viral gene delivery has become increasingly important to increase the success of clinical trials. In this study, structural domains of different rAAV serotypes isolated from primate brain were combined to create novel hybrid recombinant AAV serotypes, rAAV2/rec2 and rAAV2/rec3. The efficacy of these novel serotypes were assessed in wild type mice and in two models of retinal degeneration (the Abca4−/− mouse which is a model for Stargardt disease and in the Pde6brd1/rd1 mouse) in vivo, in primate tissue ex-vivo, and in the human-derived SH-SY5Y cell line, using an identical AAV2 expression cassette. We show that these novel hybrid serotypes can transduce retinal tissue in mice and primates efficiently, although no more than AAV2/2 and rAAV2/5 serotypes. Transduction efficiency appeared lower in the Abca4−/− mouse compared to wild type with all vectors tested, suggesting an effect of specific retinal diseases on the efficiency of gene delivery. Shuffling of AAV capsid domains may have clinical applications for patients who develop T-cell immune responses following AAV gene therapy, as specific peptide antigen sequences could be substituted using this technique prior to vector re-treatments.
first_indexed 2024-03-06T21:55:49Z
format Journal article
id oxford-uuid:4ce63ee9-7324-4257-bdae-99ed95fcc38e
institution University of Oxford
language English
last_indexed 2024-03-06T21:55:49Z
publishDate 2013
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:4ce63ee9-7324-4257-bdae-99ed95fcc38e2022-03-26T15:52:09ZAssessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retinaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4ce63ee9-7324-4257-bdae-99ed95fcc38eEnglishSymplectic Elements at OxfordPublic Library of Science2013Charbel Issa, PSilva, DLipinski, DSingh, MSMouravlev, AYou, QBarnard, AHankins, MDuring, MMaclaren, RAdeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials. Thus, improving the efficiency of viral gene delivery has become increasingly important to increase the success of clinical trials. In this study, structural domains of different rAAV serotypes isolated from primate brain were combined to create novel hybrid recombinant AAV serotypes, rAAV2/rec2 and rAAV2/rec3. The efficacy of these novel serotypes were assessed in wild type mice and in two models of retinal degeneration (the Abca4−/− mouse which is a model for Stargardt disease and in the Pde6brd1/rd1 mouse) in vivo, in primate tissue ex-vivo, and in the human-derived SH-SY5Y cell line, using an identical AAV2 expression cassette. We show that these novel hybrid serotypes can transduce retinal tissue in mice and primates efficiently, although no more than AAV2/2 and rAAV2/5 serotypes. Transduction efficiency appeared lower in the Abca4−/− mouse compared to wild type with all vectors tested, suggesting an effect of specific retinal diseases on the efficiency of gene delivery. Shuffling of AAV capsid domains may have clinical applications for patients who develop T-cell immune responses following AAV gene therapy, as specific peptide antigen sequences could be substituted using this technique prior to vector re-treatments.
spellingShingle Charbel Issa, P
Silva, D
Lipinski, D
Singh, MS
Mouravlev, A
You, Q
Barnard, A
Hankins, M
During, M
Maclaren, R
Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina
title Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina
title_full Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina
title_fullStr Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina
title_full_unstemmed Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina
title_short Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina
title_sort assessment of tropism and effectiveness of new primate derived hybrid recombinant aav serotypes in the mouse and primate retina
work_keys_str_mv AT charbelissap assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT silvad assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT lipinskid assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT singhms assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT mouravleva assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT youq assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT barnarda assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT hankinsm assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT duringm assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina
AT maclarenr assessmentoftropismandeffectivenessofnewprimatederivedhybridrecombinantaavserotypesinthemouseandprimateretina